Abstract
We evaluated herpes simplex virus type 2 (HSV-2) sero- positivity in an HIV clinic- based population with CD4 lymphocytes counts ≥250 cells/μL and no previous knowledge of HSV-2 infection by history of serology. We demonstrate that although the seroprevalence of HSV-2 is higher in this HIV-infected population, predictors of HSV-2 seropositivity are similar to those in the general population.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
AIDS-Related Opportunistic Infections / diagnosis
-
AIDS-Related Opportunistic Infections / epidemiology*
-
Antibodies, Viral
-
CD4-Positive T-Lymphocytes
-
Chlamydia Infections / epidemiology
-
Drug Users / statistics & numerical data*
-
Enzyme-Linked Immunosorbent Assay
-
Female
-
Gonorrhea / epidemiology
-
HIV Seropositivity / diagnosis
-
HIV Seropositivity / epidemiology*
-
HIV-1
-
Herpes Genitalis / diagnosis
-
Herpes Genitalis / epidemiology*
-
Herpesvirus 2, Human / isolation & purification*
-
Humans
-
Male
-
Mass Screening
-
Predictive Value of Tests
-
Prevalence
-
Prospective Studies
-
Risk Factors
-
Sexual Behavior / statistics & numerical data*
-
Syphilis / epidemiology
-
United States / epidemiology